Neonatal hyperbilirubinemia ‒ severe (2011-2013)

2011 - 2013 - Concluded

Michael Sgro, MD, FRCPC, University of Toronto, Department of Paediatrics, St. Michael’s Hospital, Room 014, 15th floor, Cardinal Carter Wing, 30 Bond St, Toronto ON M5B 1W8; tel.: 416-864-6060, ext. 6560; fax: 416-864-6073; [email protected]

Study results can be found in

CPSP 2013 Results

CPSP Highlights

Published papers

  • Severe neonatal hyperbilirubinemia decreased after the 2007 Canadian guidelines

    Sgro M, Kandasamy S, Shah V, Ofner M, Campbell D. J Pediatr 2016 Apr;171:43–7

Presentations

  • Surveillance of severe neonatal hyperbilirubinemia in Canada

    Sgro MD, Kandasamy S, Campbell D, Ofner M, Shah V. PAS/ASPR Joint Meeting, Vancouver, in May 2014 (oral)

  • Comparing rates of severe neonatal hyperbilirubinemia in three Western industrialized populations: Canada, the United Kingdom & Ireland, and Switzerland

    Sgro M, Kandasamy S, Ofner M. PAS/ASPR Joint Meeting, Vancouver, in May 2014 (poster)

  • Surveillance of severe neonatal hyperbilirubinemia in Canada: 2011-2013

    Sgro M, Kandasamy S, Campbell D, Shah V, Grenier D, Ofner M. International Congress of Pediatrics, Melbourne, in August 2013 (poster)

  • Surveillance of severe neonatal hyperbilirubinemia in Canada: 2010-2013

    Sgro M, Kandasamy S, Campbell DM, Ofner M, Shah V. Canadian Paediatric Society Annual Conference, Edmonton, in June 2013 (poster)

  • Physical examination of the newborn and group B Streptococcus

    Sgro M. Midwifery Clinical Skills Course, Ryerson University, Toronto, in November 2012 (oral)

Related links